M&A

Harmony Biosciences (HRMY) Form 144 Filed on May 8

Published on 5/8/2026

#HRMY#SEC#Form144
Harmony Biosciences (HRMY) Form 144 Filed on May 8

AI Summary

Harmony Biosciences (HRMY) submitted Form 144 on May 8. Form 144 is used by an insider or affiliate to notify the SEC of proposed sales of stock, indicating potential changes in ownership. This filing often provides insight into future trading activity and liquidity for the company's shares. Market participants typically keep an eye on these forms as they can affect investor sentiment regarding the stock's stability and performance.

Source: Read original article (opens in new tab)

Related News

Airbnb (ABNB) Faces Lawsuit in Chicago; Price Target Raised to $134
M&A

Airbnb (ABNB) Faces Lawsuit in Chicago; Price Target Raised to $134

Jun 27

Dell Technologies (DELL) Ends Partnership with Arrow Electronics for $1.4B
M&A

Dell Technologies (DELL) Ends Partnership with Arrow Electronics for $1.4B

Jun 27

Savara (SVRA) CFO Executes 580,187 Options, Sells 394,528 Shares
Earnings

Savara (SVRA) CFO Executes 580,187 Options, Sells 394,528 Shares

Jun 27

Saks (SKT) Emerges From Chapter 11 Bankruptcy With Reduced Debt
M&A

Saks (SKT) Emerges From Chapter 11 Bankruptcy With Reduced Debt

Jun 27